Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata

von Chamie, G., Luetkemeyer, A., Walusimbi-Nanteza, M., Okwera, A., Whalen, C. C., Mugerwa, R. D., Havlir, D. V., Charlebois, E. D.
Veröffentlicht 2010

A172 C-EDGE CO-STAR: RISK OF REINFECTION FOLLOWING SUCCESSFUL THERAPY WITH ELBASVIR (EBR) AND GRAZOPREVIR (GZR) IN PERSONS WHO INJECT DRUGS (PWID) RECEIVING OPIOD AGONIST THERAPY (...

von Conway, B, Dore, G J, Altice, F, Litwin, A, Grebely, J, Dalgard, O, Gane, E J, Shibolet, O, Luetkemeyer, A, Nahass, R, Peng, C, Gendrano, I, Huang, H, Chen, E, Nguyen, B, Wahl, J, Barr, E, Robertson, M, Platt, H
Veröffentlicht in J Can Assoc Gastroenterol (2018)

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

von Havlir, D. V., Kendall, M. A., Ive, P., Kumwenda, J., Swindells, S., Qasba, S. S., Luetkemeyer, A. F., Hogg, E., Rooney, J., Wu, X., Hosseinipour, M. C., Lalloo, U., Veloso, V. G., Some, F. F., Kumarasamy, N., Padayatchi, N., Santos, B. R., Reid, S., Hakim, J., Mohapi, L., Mugyenyi, P., Sanchez, J., Lama, J. R., Pape, J. W., Sattler, F. R., Asmelash, A., Moko, E., Sawe, F., Andersen, J., Sanne, I.
Veröffentlicht 2011